Compatibility Testing of Packaging Materials for Traditional Chinese Medicine: Technical Principles,

Traditional Chinese medicine (TCM) packaging material compatibility testing evaluates the interactions between complex herbal formulations and their container closure systems to ensure product safety, quality, and regulatory compliance throughout the shelf life. This technical guide covers extractables and leachables studies, sample types, analytical methods, and applicable standards such as YBB, ICH Q3E, ICH Q3D, and USP chapters. It is written for pharmaceutical manufacturers, packaging suppliers, and quality professionals involved in TCM product development, registration, and change management.

Technical Overview

Compatibility testing of packaging materials for traditional Chinese medicine (TCM) is a systematic scientific study that characterizes potential interactions between a drug product and its container closure system. Unlike small-molecule chemical drugs, TCM formulations such as oral liquids, mixtures, tinctures, injections, granules, pills, and topical preparations contain complex phytochemical matrices, including volatile essential oils, phenolic acids, flavonoids, glycosides, alkaloids, tannins, and polysaccharides. These constituents can migrate into packaging materials, adsorb onto inner surfaces, or chemically react with packaging components, resulting in loss of therapeutic activity or degradation of key markers.

Conversely, substances originating from packaging materials, such as plasticizers, antioxidants, residual monomers, oligomers, polymerization initiators, slip agents, lubricants, and elemental impurities, may leach into the product and pose toxicological risk to patients. The objective of a compatibility study is therefore twofold: to demonstrate that the packaging system adequately protects the drug product and that no harmful or performance-affecting levels of leachables accumulate under intended storage conditions.

The regulatory and pharmacopeial framework for these studies in China and internationally includes the national pharmaceutical packaging material standards (YBB series), the Chinese Pharmacopoeia general chapters on drug packaging systems, the technical guidance on compatibility studies for injections and plastic packaging materials, ICH Q3E on extractables and leachables, ICH Q3D on elemental impurities, USP general chapters on extractables and leachables assessment, and ISO 10993 for biological evaluation where applicable.

Testing Samples

Glass Containers

Glass packaging for TCM products includes ampoules for injectable preparations, tubular vials, oral liquid bottles, and syrup bottles. Testing focuses on hydrolytic resistance classification, delamination risk for borosilicate tubing, extractable alkali ions (sodium, potassium, boron, silicon, aluminum), arsenic and heavy metal release, and inner surface durability after contact with aqueous or ethanol-containing herbal extracts.

Plastic Containers and Bottles

Common polymeric materials include polyethylene terephthalate (PET), high-density polyethylene (HDPE), low-density polyethylene (LDPE), and polypropylene (PP) used for oral liquid bottles, dropper bottles, mixture bottles, and infusion containers. Studies characterize oligomers, residual catalysts, plasticizers such as di(2-ethylhexyl) phthalate (DEHP) and di(2-ethylhexyl) adipate (DEHA), bisphenol A, phenolic antioxidants such as Irganox 1010 and 1076, and phosphite processing stabilizers such as Irgafos 168.

Flexible Laminated Films and Pouches

Composite structures such as PET/AL/PE, BOPP/AL/PE, and paper/AL/PE are widely used for herbal granules, powders, and tea bags. Compatibility testing evaluates residual solvents from printing inks and adhesives, primary aromatic amines from polyurethane laminating adhesives, layer delamination, and seal integrity after contact with hygroscopic or volatile-oil-containing granules.

Elastomeric Closures and Composite Components

Rubber stoppers for injection vials, gaskets for oral liquid bottles, and septa for dropper bottles are studied for vulcanization accelerators, 2-mercaptobenzothiazole and related thiazoles, nitrosamines, polycyclic aromatic hydrocarbons, zinc and other metal accelerators, as well as adsorption of herbal active markers onto the elastomer surface.

Metal Packaging

Collapsible aluminum tubes for TCM ointments and creams, blister foils, and metal laminates are tested for metal ion migration, coating extractables, and corrosion resistance when contacted with acidic or phenolic herbal matrices.

Testing Items

A comprehensive compatibility protocol for TCM packaging typically includes the following test categories:

• Extractables profiling: systematic characterization of organic and inorganic substances released from packaging under aggressive laboratory extraction conditions, including simulation with solvents that mimic the drug product formulation, such as purified water, pH buffers, and ethanol-water mixtures for tinctures and spirits.
• Leachables quantification: targeted and non-targeted measurement of substances migrating into the actual drug product under long-term and accelerated storage conditions at multiple time points through the proposed shelf life.
• Elemental impurities and heavy metals: quantification of lead, cadmium, arsenic, mercury, cobalt, antimony, barium, zinc, and aluminum released from glass, pigments, and polymer additives, evaluated against permitted exposure limits and ICH Q3D principles.
• Target analyte screening: specific determination of high-concern migrants including phthalate esters (DEHP, DBP, DINP), bisphenol A, antioxidant degradation products, styrene, acrylonitrile, vinyl chloride monomer, caprolactam, and nitrosamines.
• Adsorption and uptake studies: assessment of the loss of volatile essential oil constituents (for example, menthol, eugenol, ligustilide) and marker compounds through adsorption onto or absorption into the packaging material.
• Physicochemical compatibility: monitoring of appearance, color, turbidity, pH shift, precipitation, and visible or subvisible particulate formation during contact studies.
• Barrier and protection performance: water vapor transmission rate, oxygen transmission rate, light transmission, and seal integrity relevant to moisture-sensitive granules and oxidation-prone extracts.
• Biological reactivity: cytotoxicity testing, hemolysis testing for blood-contacting dosage forms, and intracutaneous or sensitization studies where the risk assessment indicates a need.

Testing Methods

The scientific approach follows the established risk-based paradigm of extraction study followed by simulation and migration study, supported by toxicological assessment.

Extraction and Simulation Studies

Extraction studies are performed on packaging components using solvents with comparable polarity, pH, and alcohol content to the drug product. Conditions are intensified relative to intended use, for example, elevated temperatures of 40 to 70 degrees Celsius, extended extraction durations, and inversion or agitation to maximize surface contact. The resulting extract is profiled analytically to build a target list of potential leachables.

Instrumental Analysis

• Gas chromatography coupled with mass spectrometry (GC-MS) for volatile and semi-volatile organic extractables, including residual solvents, monomers, and plasticizers.
• Headspace GC-MS for highly volatile residual solvents from inks, adhesives, and polymer residues.
• Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) and high-resolution LC-MS for non-volatile organic extractables, oligomers, and antioxidant degradants such as 2,4-di-tert-butylphenol and 3,5-di-tert-butyl-4-hydroxybenzaldehyde.
• High-performance liquid chromatography with UV or fluorescence detection for routine targeted leachables quantification.
• Inductively coupled plasma mass spectrometry (ICP-MS) or ICP-OES for elemental impurities at trace levels.
• Ion chromatography for inorganic anions and small organic acids from glass surface extraction.

Analytical Evaluation Threshold and Reporting

The analytical evaluation threshold (AET) is derived from the safety concern threshold (SCT) of 1.5 micrograms per day, the maximum daily dose of the drug product, and the number of dosage units contacted by the packaging system, followed by application of an uncertainty factor, commonly 50 percent, to account for analytical response variability. All extractables and leachables exceeding the AET are identified, quantified, and subjected to toxicological evaluation against established permissible exposure levels such as the qualified person's toxicological assessment thresholds or ICH M7 principles where structurally alerting.

Method Validation and Study Design

Validated stability-indicating methods are required for routine leachables monitoring, covering specificity, linearity, range, accuracy, recovery, precision, limit of detection, and limit of quantification consistent with ICH Q2(R2). Migration studies are conducted under long-term and accelerated stability conditions, for example, 25 degrees Celsius with 60 percent relative humidity and 40 degrees Celsius with 75 percent relative humidity, with sampling at initial, intermediate, and final time points, often including inverted and upright storage orientations for liquid products.

Toxicological Risk Assessment

Identified leachables are evaluated by comparing calculated daily patient exposure against safety-derived acceptable intake values. Where literature data are unavailable, in silico quantitative structure-activity relationship tools and read-across approaches are applied. The final report concludes whether the packaging system is suitable for its intended use with the specific TCM formulation.

Applications

Compatibility testing data serve multiple purposes across the product life cycle:

• Drug registration dossiers submitted to national regulatory authorities, supporting the pharmaceutical development section and the packaging component information for new TCM applications, generic oral liquids, and herbal injections.
• Packaging material registration and supplier qualification, including the drug master file type III packaging component submissions in regulated export markets.
• Formulation development support for selecting between glass, polymer, and laminate options based on volatile oil retention, adsorption behavior, and leachables profiles.
• Stability program design, ensuring leachables monitoring is integrated into registration and ongoing stability protocols.
• Post-approval change management when switching packaging suppliers, materials, manufacturing sites, or container configurations.
• Export registration to markets governed by FDA, EMA, WHO prequalification, and ASEAN requirements, where E&L data packages are prerequisites.
• Root cause investigation of market complaints involving precipitation, discoloration, odor change, or container defects.

FAQ

What is the difference between extractables and leachables?

Extractables are compounds that can be forced out of packaging materials under exaggerated laboratory conditions such as high temperature and aggressive solvents, while leachables are the subset that actually migrates into the drug product under normal storage and use conditions. Extractables studies generate the candidate list; leachables studies confirm what patients are actually exposed to.

Why do TCM products require special compatibility considerations compared with chemical drugs?

TCM formulations contain hundreds of coexisting phytochemicals, often with high ethanol content, volatile essential oils, and tannins that can accelerate polymer additive extraction, adsorb onto closures, or chemically interact with packaging surfaces. The complex matrix also creates analytical background interference, demanding highly selective methods and matrix-matched validation.

Which regulatory standards govern TCM packaging compatibility testing?

In China, the YBB national packaging standards, the Chinese Pharmacopoeia general chapters on packaging systems, and the compatibility technical guidance documents for injections apply. Internationally, ICH Q3E, ICH Q3D, USP chapters on extractables and leachables, and the EP general chapters on plastic materials are commonly referenced.

How long does a complete compatibility study take?

A full program, including extraction studies, method development and validation, and a six-month migration study under accelerated and long-term conditions, typically requires nine to twelve months. Simulated-use screening studies can be completed in two to four months for early development decisions.

How is the analytical evaluation threshold calculated for an oral liquid TCM product?

The AET in micrograms per milliliter equals the SCT of 1.5 micrograms per day divided by the maximum daily volume of product contacted by the packaging, multiplied by an uncertainty factor of 50 percent to ensure adequate analytical sensitivity for all reported results.

Do herbal granules in composite film pouches require full E&L testing?

Yes, when the granules contain volatile oils or the laminate uses polyurethane adhesives, migration of primary aromatic amines and residual solvents must be evaluated, although dry solid dosage forms generally present lower migration risk than liquid formulations and may justify a streamlined, risk-based protocol.